Zoubeidi, Amina

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

Quigley, D. A., Dang, H. X., Zhao, S. G., Lloyd, P., Aggarwal, R., Alumkal, J. J., Foye, A., Kothari, V., Perry, M. D., Bailey, A. M., et al. (2018) · Cell

Prostate Cancer Treatment and ResearchCancer Genomics and Diagnostics

Cited by 733

Cellular plasticity and the neuroendocrine phenotype in prostate cancer

Davies, A. H., Beltran, H., & Zoubeidi, A. (2018) · Nature Reviews Urology

Prostate Cancer Treatment and ResearchCancer Cells and Metastasis

Cited by 431

Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1

Hsu, E.-C., Rice, M. A., Bermudez, A., Marques, F. J. G., Aslan, M., Liu, S., Ghoochani, A., Zhang, C. A., Chen, Y.-S., Zlitni, A., et al. (2020) · Proceedings of the National Academy of Sciences

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 146

Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts

Trerotola, M., Ganguly, K. K., Fazli, L., Fedele, C., Lu, H., Dutta, A., Liu, Q., De Angelis, T., Riddell, L. W., Riobo, N. A., et al. (2015) · Oncotarget

Prostate Cancer Treatment and ResearchCell Adhesion Molecules Research

Cited by 70